Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;25(2):605-611.
doi: 10.1007/s10561-023-10122-z. Epub 2024 Jan 3.

Impact of COVID-19 pandemic on cord blood banking and transplantation

Liane Marise Röhsig  1   2 , Nance Beyer Nardi  3
Affiliations
Review

Impact of COVID-19 pandemic on cord blood banking and transplantation

Liane Marise Röhsig et al. Cell Tissue Bank. 2024 Jun.

Abstract

Umbilical cord blood is a rich source of hematopoietic stem cells that has been used for transplantation for over 30 years, especially when there is no compatible hematopoietic stem cell donor available. Its use has decreased more recently, since the development of methods to improve haploidentical transplants has allowed the use of mobilized peripheral blood as a source of hematopoietic stem cells. Public cord blood banks collect, process and store cord blood samples from voluntary donations. In addition, many public banks are involved in research to enhance hematopoietic stem cell therapies and develop new treatments for haematological and genetic diseases. The COVID-19 pandemic, which emerged in 2019, has had a profound and wide-ranging impact on human health and treatment. The area of hematopoietic stem cell transplantation was deeply affected by reductions in bone marrow, peripheral blood and cord blood donations; logistical challenges; exposure of healthcare workers and other challenges. The present study reviews the impact of the COVID-19 pandemic on cord blood banking and transportation around the world with a special focus on Brazil.

Keywords: Cord blood bank; Covid-19 pandemic; Hematopoietic stem cell; REDOME; Transplantation.

PubMed Disclaimer

References

    1. Algwaiz G, Aljurf M, Koh M et al (2020) Real-world issues and potential solutions in hematopoietic cell transplantation during the COVID-19 pandemic: perspectives from the worldwide network for blood and marrow transplantation and center for international blood and marrow transplant research health services and international studies committee. Biol Blood Marrow Transpl 26(12):2181–2189. https://doi.org/10.1016/j.bbmt.2020.07.021 - DOI
    1. Allan DS, Green M, Morris G et al (2022) Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: a Canadian blood services stem cell registry analysis. Vox Sang 117(9):1121–1125. https://doi.org/10.1111/vox.13294 - DOI - PubMed
    1. Anurogo D, Yuli Prasetyo Budi N, Thi Ngo MH, Huang YH, Pawitan JA (2021) Cell and gene therapy for anemia: hematopoietic stem cells and gene editing. Int J Mol Sci 22(12):6275. https://doi.org/10.3390/ijms22126275 - DOI - PubMed - PMC
    1. Ardura M, Hartley D, Dandoy C et al (2020) Addressing the impact of the coronavirus Disease 2019 (COVID-19) pandemic on hematopoietic cell transplantation: learning networks as a means for sharing best practices. Biol Blood Marrow Transpl 26(7):e147–e160. https://doi.org/10.1016/j.bbmt.2020.04.018 - DOI
    1. Auletta JJ, Novakovich JL, Stritesky GL et al (2021) Meeting the demand for unrelated donors in the midst of the COVID-19 pandemic: rapid adaptations by the national Marrow donor program and its network partners ensured a safe supply of donor products. Transpl Cell Ther 27(2):133–141. https://doi.org/10.1016/j.jtct.2020.10.014 - DOI

LinkOut - more resources